|
MCID: BTT002
|
Beta Thalassemia malady |
|
1 drug, 111 genes, 9 tissues, 825 related diseases, 21 phenotypes, 325 articles, clinical trials, genetic tests.
|
|
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 15GeneReviews, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Beta-thalassemia is a blood disorder that reduces the production of hemoglobin. Without sufficient hemoglobin, red blood cells do not develop normally, causing a shortage of mature red blood cells, leading to anemia and other health problems. Severe beta-thalassemia is called “thalassemia major” or “Cooley’s anemia.” Thalassemia intermedia is the less severe form. Mutations in the HBB gene cause beta-thalassemia. This condition is usually inherited in an autosomal recessive fashion, which means people with beta thalassemia have mutations in both of their HBB genes. People who have only one HBB mutation may have no symptoms or develop mild symptoms; these individuals are said to have thalassemia minor.30
MalaCards: Beta Thalassemia, also known as mediterranean anemia, is related to hemoglobin s beta-thalassemia and alpha thalassemia. An important gene associated with Beta Thalassemia is HBG1 (hemoglobin, gamma A), and among its related pathways are O2/CO2 exchange in erythrocytes and Factors involved in megakaryocyte development and platelet production. The drug phenylbutyrate sodium and the compounds cyclophosphamide and citrate have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, brain and liver, and related mouse phenotypes are respiratory system and endocrine/exocrine gland. Genetics Home Reference: Beta thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body.17 Wikipedia: Beta-thalassemias (β-thalassemias) are a group of inherited blood disorders caused by reduced or absent...44 more... OMIM: 604131 GeneReviews summary for b-thal |
|
Sources: 2CDC, 6Disease Ontology, 17Genetics Home Reference, 8DISEASES, 43UMLS, 7diseasecard, 44Wikipedia, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 32Novoseek , 33OMIM, 24MeSH, 40SNOMED-CT, 27NCIt See all sources |
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 604131
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for beta thalassemia Drug clinical trials:Search ClinicalTrials for beta thalassemia Search NIH Clinical Center for beta thalassemia Search CenterWatch for beta thalassemia Inferred drug relations via UMLS/NDF-RT:43 28 phenylbutyrate sodium |
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to beta thalassemia:22Bone marrow, Brain, Liver, T cells, B cells, Fetal brain, Pons, Fetal liver, Pituitary
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to beta thalassemia:25 (show all 21)
|
|
Sources: 35PubMed See all sources |
Articles related to beta thalassemia:(show top 50) (show all 325)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 38Reactome, 34PharmGKB, 41Thomson Reuters, 10EMD Millipore, 36QIAGEN, 20KEGG See all sources |
Pathways related to beta thalassemia according to GeneDecks:(show all 32)
|
|
Sources: 32Novoseek , 34PharmGKB, 9DrugBank, 18HMDB, 42Tocris Bioscience See all sources |
Compounds related to beta thalassemia according to GeneDecks:(show top 50) (show all 529)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to beta thalassemia according to GeneDecks:
Biological processes related to beta thalassemia according to GeneDecks:(show all 14)
Molecular functions related to beta thalassemia according to GeneDecks:(show all 10)
|
